Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Lisa_Anson
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:developedBy |
small molecule drugs
|
| gptkbp:focusesOn |
oncology
fibrosis |
| gptkbp:founded |
2010
|
| gptkbp:headquarters_location |
gptkb:Alderley_Park,_Cheshire,_England
|
| https://www.w3.org/2000/01/rdf-schema#label |
Redx Pharma
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:listedOn |
gptkb:AIM_(Alternative_Investment_Market)
|
| gptkbp:notableProduct |
gptkb:RXC004
gptkb:RXC007 |
| gptkbp:stockSymbol |
gptkb:REDX
|
| gptkbp:website |
https://www.redxpharma.com/
|
| gptkbp:bfsParent |
gptkb:Alderley_Park,_Cheshire,_England
|
| gptkbp:bfsLayer |
6
|